Osteomalacia induced peripheral neuropathy after obesity reduction surgery.

Osteomalacia and rickets are important reversible causes of debilitating muscular weakness and bony pains in India among all socio-economic strata and...
1MB Sizes 3 Downloads 0 Views

Recommend Documents


Obesity increases the risk of postoperative peripheral neuropathy after minimally invasive colon and rectal surgery.
Abdominal surgery in the obese can be a major challenge in the perioperative period. Peripheral neuropathy is an uncommon but well-described complication after abdominal surgery.

Chemotherapy-induced peripheral neuropathy.
Chemotherapy-induced peripheral neuropathy (CIPN) is common in patients receiving anticancer treatment and can affect survivability and long-term quality of life of the patient following treatment. The symptoms of CIPN primarily include abnormal sens

Symptoms: Chemotherapy-Induced Peripheral Neuropathy.
Chemotherapy-induced peripheral neuropathy (CIPN) is a problematic, treatment-induced toxicity that has the potential to impact quality of life and limit the doses of curative intent therapy. This therapy-induced side effect is one of the most troubl

Linezolid Induced Reversible Peripheral Neuropathy.
Linezolid has been increasingly used for several severe infections including multidrug-resistant tuberculosis. Peripheral neuropathy is a rare side effect of linezolid and is conventionally considered as irreversible. Here, we report a case of revers

Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.
Chemotherapy-induced neuropathy is a common, dose-dependent adverse effect of several antineoplastics. It can lead to detrimental dose reductions and discontinuation of treatment, and severely affects the quality of life of cancer survivors. Clinical

Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy.
Paclitaxel is used worldwide in the treatment of breast, lung, ovarian, and other cancers. Sensory peripheral neuropathy is an associated adverse effect that cannot be predicted, prevented, or mitigated. To better understand the contribution of germl

Chemotherapy-induced peripheral neuropathy in the adult.
This review focuses on the newest data on mechanistic aspects of chemotherapy-induced peripheral neuropathy (CIPN), its assessment and the current status of neuroprotection and treatment options.

New guidelines for chemotherapy-induced peripheral neuropathy.
The focus of this column is to present topics of interest from a variety of journals to Oncology Nursing Forum readers. The topic of this issue is the release of new and adapted survivorship guidelines from the American Society of Clinical Oncology.

Rodent models of chemotherapy-induced peripheral neuropathy.
Peripheral neuropathy is a common and dose-limiting side effect of many chemotherapeutic drugs. These include platinum compounds, taxanes, vinca alkaloids, proteasome inhibitors, and others such as thalidomide and suramin. Although many rodent models